Clinical Pathology: Genetic Testing

• Amyotrophic lateral sclerosis (ALS) is a progressive, late-onset motor neuron disease caused by selective premature degeneration and death of upper and lower motor neurons in the motor cortex, brain stem, and spinal cord.

• The disease starts in adult life, typically between 50 and 60 years of age.

• The ensuing progressive paralysis is typically fatal within 3 to 5 years of clinical onset, usually as a result of failure of the respiratory system.

• ALS is one of the more prevalent adult-onset neurodegenerative diseases, with an incidence of 1 to 2 per 100,000 in most populations. The incidence is much higher in the Pacific island of Guam and the Kii Peninsula of Japan, possibly because of consumption of an environmental toxin, β-methylamino-L-alanine.

• The cause of ALS is unknown in most cases, and these cases are referred to as sporadic ALS (SALS).

• Approximately 10% of ALS cases are inherited in a dominant manner and are referred to as familial ALS (FALS).

• To date, mutations in 12 genes have been reported to cause FALS. Among these, SOD1 mutations, which are transmitted in a dominant fashion, account for approximately 20% of all familial ALS forms and about 2% of all ALS cases.

Boillee S, Vande Velde C, Cleveland D: ALS: a disease of motor neurons and their nonneuronal neighbors.Neuron 2006;52:39–59.

Anderson P, Al-Chalabi A: Clinical genetics of amyotrophic lateral sclerosis: what do we really know?Nat Rev 2011;7:603–615.

Barber S, Shaw P: Oxidative stress in ALS: key role in motor neuron injury and therapeutic target.Free Radic Biol Med 2010;48:629–641.

 
* = Required 
* Note Title
* Note